First Light Asset Management’s Myriad Genetics MYGN Stock Holding History

First Light Asset Management’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-7,820	Closed	-$239K	–	69
2016 Q2	$239K	Hold	7,820	–	–	0.11%	63
2016 Q1	$293K	Hold	7,820	–	–	0.15%	62
2015 Q4	$338K	Hold	7,820	–	–	0.14%	62
2015 Q3	$293K	Hold	7,820	–	–	0.14%	58
2015 Q2	$266K	Hold	7,820	–	–	0.13%	60
2015 Q1	$277K	Hold	7,820	–	–	0.14%	60
2014 Q4	$266K	Hold	7,820	–	–	0.15%	63
2014 Q3	$302K	Hold	7,820	–	–	0.21%	61
2014 Q2	$304K	Hold	7,820	–	–	0.2%	63
2014 Q1	$267K	Buy	+7,820	New	+$242K	0.19%	68

Other funds holding MYGN

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

First Light Asset Management's MYGN Position: Q3 2016 in Review

First Light Asset Management sold out of Myriad Genetics (MYGN) in Q3 2016, closing a stake of 7,820 shares — an estimated $239K sold.

First Light Asset Management first reported a position in MYGN in Q1 2014 and held it in 10 quarters. The position peaked at $338K in Q4 2015. 223 funds tracked by Wall St. Rank hold MYGN as of Q3 2016.

First Light Asset Management reported no remaining Myriad Genetics position as of Q3 2016 after selling out during the quarter.
First Light Asset Management sold 7,820 Myriad Genetics shares in Q3 2016, an estimated $239K.
First Light Asset Management first reported a position in Myriad Genetics in Q1 2014 and held it in 10 quarters.
First Light Asset Management's Myriad Genetics position peaked at $338K in Q4 2015.
223 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2016.

Based on First Light Asset Management's 13F filing for Q3 2016, filed 15 Nov 2016.